Figure 3.
Figure 3. CD33 sorting strategy for AML and engraftment time course of sorted fractions. AML MNCs were stained with anti-CD33 antibody and sorted into CD33- and CD33+ fractions. (A) AML cells stained with isotype control. (B) AML cells stained with anti-CD33 antibody and sort gates G1 and G2. Purity of the sorted CD33- (C) and CD33+ (D) fractions of AML. Engraftment of CD33+ and CD33- fractions of AML samples no. 1 (E) and no. 9 (F) at 6 and 12 weeks. Filled squares represent mice given CD33- cells. Open squares represent mice given CD33+ cells.

CD33 sorting strategy for AML and engraftment time course of sorted fractions. AML MNCs were stained with anti-CD33 antibody and sorted into CD33- and CD33+ fractions. (A) AML cells stained with isotype control. (B) AML cells stained with anti-CD33 antibody and sort gates G1 and G2. Purity of the sorted CD33- (C) and CD33+ (D) fractions of AML. Engraftment of CD33+ and CD33- fractions of AML samples no. 1 (E) and no. 9 (F) at 6 and 12 weeks. Filled squares represent mice given CD33- cells. Open squares represent mice given CD33+ cells.

Close Modal

or Create an Account

Close Modal
Close Modal